CN1480129A - Ground substance and plaster of Chinese traditional medicine as well as its preparing method - Google Patents
Ground substance and plaster of Chinese traditional medicine as well as its preparing method Download PDFInfo
- Publication number
- CN1480129A CN1480129A CNA031352448A CN03135244A CN1480129A CN 1480129 A CN1480129 A CN 1480129A CN A031352448 A CNA031352448 A CN A031352448A CN 03135244 A CN03135244 A CN 03135244A CN 1480129 A CN1480129 A CN 1480129A
- Authority
- CN
- China
- Prior art keywords
- polyisobutylene
- chinese medicine
- medicine plaster
- stroma
- plaster
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicinal Preparation (AREA)
Abstract
A matrix for Chinese-medicinal plaster is prepared from polyisobutylene, viscosity increaser, softening agent, filler, percutaneous absorption promoter, and solvent. Its advantages are low hypersensitivity and irritation to skin, and controllable viscosity. Its Chinese-medicinal plaster is prepared through proportionally mixing said matrix with the Chinese-medicinal extract.
Description
(1) technical field:
The present invention relates to a kind of plaster stroma, particularly a kind of Chinese medicine plaster stroma the invention still further relates to the Chinese medicine plaster of the above-mentioned substrate of use and their preparation method.
(2) background technology:
The patch therapy is one of five traditional big dosage forms of China, owing to be subjected to the restriction of substrate (carrier), rest on traditional black plaster for a long time on the stage, because black plaster is leaded and the pre-thermal softening of normal palpus is used inconvenient, more easily pollute skin and clothes, replaced by rubber mass gradually.The Chinese medicine rubber plaster overcome traditional black plaster use inconvenient, easily pollute defective such as clothes, but bad medicine behaviors such as stripping reaction, anaphylaxis, irritant reaction easily take place in rubber-emplastrum, suitable crowd limits to some extent.
Learn that after deliberation the scytitis that adhesive plaster with medicine causes reason hypersensitive has following aspect:
1, stripping reaction: when skin is taken rubber plaster off, because the physics wound can cause erythema, slight edema, the adhesion of adhesive plaster with medicine is big more, easily more causes this inflammation, peels off the stripping reaction that produces in the short time of back, is caused by the adhesiveness of adhesive plaster with medicine.
2, anaphylaxis: anaphylactoid lesion tissue of rubber plaster and contact dermatitis are similar, occur after being reflected at a few hours of applying ointment or plaster, arrive summit in 24～72 hours, reaction is persistence, after rubber plaster is peeled off, inflammation still can continue, and scope surmounts former application site, is caused by ingredient in the rubber plaster.
3, irritant reaction: after rubber plaster was applied ointment or plaster, the outermost horny layer of skin surface made sweat gland mouth obturation then very easily because of irriate causes hyperkeratosis, hindered the drainage of perspiration; Perspiration is detained, cause the skin dipping softening, make whiteness of skin, deliquescing, simultaneously also make the tissue of skin become good culture medium with suitable humiture, microorganism such as antibacterial and fungus is bred easily at skin surface, cause antiperspirant pipe and follicular infection and eczema, after being applied ointment or plaster by rubber plaster, skin is airtight wet thoroughly and cause.
Show according to the sensitization test (STT) to each individual event composition of adhesive plaster with medicine: natural rubber, Colophonium, antiseptic are strong sensitinogens, and the protein in the natural rubber is real " arch-criminal " hypersensitive, and other component liquids paraffin and zinc oxide are non-anaphylactogen.
Just be devoted to research and develop novel transdermal absorption system (TDS) from the eighties abroad, having occurred adopting polyisobutylene on the medical market is the TDS product of substrate such as nitroglycerin, fentanyl, nicotine etc., but the principal agent of these plaster all is Western medicine of daily dose milligram level.
For ease of contrast, will have now during the main matrix performance is listed in the table below.
Various plaster stroma contrast tables
| The substrate title | Pluses and minuses |
| Rubber cream | Technical maturity.But irritated rate height, adhesive hair epilation phenomenon is serious, and difficulty is peeled off. |
| Fat-soluble polyacrylate | Technology is mature on the whole, and irritated rate is low.But solid content is low, and then content of dispersion is few.As improve content of dispersion, and then repeatedly coating, production efficiency is low, repeatedly is heated, and drug loss is serious. |
| The water-soluble polyacrylate class | Good biocompatibility does not have irritated.But poor to the Chinese medicine compatibility, Chinese medicine ingredients is easily moved out of mastic, unstable product quality. |
| Gel | Technology still can, irritated rate is low.But difficult dry, drug loss is serious, is not suitable for producing big containing amount Chinese medicine plaster. |
| Silicone rubber | Good biocompatibility does not have irritated.But poor to the Chinese medicine compatibility, Chinese medicine ingredients is easily moved out of mastic, unstable product quality. |
| Black plaster | Contaminated environment, cohesiveness is poor, and weatherability is poor, uses inconvenience, unhygienic, irritated rate height. |
| Polyisobutylene | This patent prescription, preparation technology is feasible, but industrialized great production.Constant product quality, irritated rate is low, and adhesive hair epilation phenomenon is light, easily peels off. |
Polyisobutylene is a synthetic high polymer, can be used as the bank or the carrier material of medicine, regulate the rate of release of medicine, have biocompatibility, the skin nonirritant, do not cause allergic reaction, have enough strong adhesion and cohesive strength, chemical property is stable, to temperature and moisture stable, and have can bonding dissimilar skins adaptability, can hold a certain amount of medicine and transdermal absorption accelerator and not influence chemical stability and adhesion.This product stable in properties, tolerance to cold, thermostability and ageing resistance are good, are the main matrix and the carrier glue of chewing gum, and 5 grams are chewed and do not shifted in 15 minutes, safety non-toxic, can not produce skin stimulates, and is the medicinal auxilliary system of safety non-toxic, has fundamentally overcome zest, the sensitization problem of substrate to skin, reduced the skin allergy rate, the skin allergy rate is reduced to less than 1% by 20% of rubber cream, has solved the high problem of the irritated rate of plaster, has widened the suitable crowd of plaster and has been suitable for sick the kind.
But the existing Western medicine that is daily dose milligram level with polyisobutylene as its principal agent of plaster of substrate that uses, owing to can't solve the little problem of polyisobutenyl confrontation Chinese medicine containing amount always, if after in substrate, adding too much medicine, other index of substrate, as tack, hold viscosity, cohesive strength etc. and can't reach requirement, therefore it can't be applied in the Chinese medicine plaster always.Though application number is 96104657.0, name is called the Chinese patent of " efficient quick-acting Chinese medicine transdermal slow-release pad pastings of a kind of antianginal and preparation thereof ", a kind of polyisobutylene that added is disclosed, azone, the topical agent of liquid paraffin and the volatile oil that from Chinese medicine, extracts, application number is 9600941.5, the patent of title " membrane controlled release type scopolamine paster " then discloses polyisobutylene, liquid paraffin is dissolved in chloroform and mixes the Chinese medicine paster that scopolamine is a bin-storing layer, one deck adhered layer all need be set again to guarantee the stickup performance of plaster on the bin-storing layer of Chinese traditional medicine layer part but include in above-mentioned two patents, and its Chinese medicinal ingredients that comprises is ethereal oil or alkaloid, the deal of medicine is few, even if contain a spot of ethereal oil of Chinese medicine or alkaloid, can not guarantee that still it has good stickup performance, can only be as bin-storing layer, therefore above-mentioned prescription can't provide the Chinese medicine plaster stroma of the Chinese medical concrete that can contain q.s.
(3) summary of the invention:
The present invention will disclose a kind of stickup performance good, peel off suitable, do not pull off the feather of, irritated rate is low, the power of releasing thoroughly is strong and the efficacy of a drug drug effect retention time is long, pharmaceutical pack Chinese medicine plaster stroma capacious, the present invention is also with the Chinese medicine plaster of the above-mentioned substrate of public use and their preparation method.
This Chinese medicine plaster stroma mainly is to be made by polyisobutylene and solvent, and polyisobutylene is a main composition in the substrate, constitutes plaster high strength skeleton.It is for itself having the synthesized polymer material of viscosity, and to the light-coloured transparent elastomer, molecular weight several thousand is to hundreds of thousands, stable in properties, safety non-toxic from water white thick liquid for form.
Polyisobutylene typical products kind and specification
| Vistanex (Exxon company) | Opanol (BASF AG) | ????Mar |
| ????B-1 | ????0.1×10 3 | |
| ????B-3 | ????0.3×10 3 | |
| ????LM-MS | ????(0.87～1.0)×10 4 | |
| ????LM-MS | ????B-10 | ????(0.1～1.17)×10 4 |
| ????B-15 | ????～1.5×10 4 | |
| ????B-50 | ????～5.0×10 4 | |
| ????MM-L80 | ????B-80 | ????(6.4～8.1)×10 4 |
| ????MM-L100 | ????B-100 | ????(8.1～9.9)×10 4 |
| ????MM-120 | ????B-120 | ????(9.9～11.7)×10 4 |
| ????MM-140 | ????(11.7～13.5)×10 4 | |
| ????B-150 | ????～1.5×10 5 | |
| ????MM-L200 | ????B-200 | ????(1.79～2.1)×10 5 |
The plaster stroma of existing product uses the polyisobutylene of single model basically, and particularly macromolecule Mar molecular weight is in (8.1～9.9) * 10
4Above polyisobutylene is a Main Ingredients and Appearance, polyisobutylene in the Chinese medicine plaster stroma of the present invention is that the polyisobutylene by macromolecule and small-molecular weight mixes, and the polyisobutylene of general small-molecular weight accounts for 10%～60% of polyisobutylene gross weight, and the polyisobutylene of macromolecule accounts for 40%～90% of polyisobutylene gross weight; The polyisobutylene that its better ratio is a small-molecular weight accounts for 30%～60% of polyisobutylene gross weight, and the polyisobutylene of macromolecule accounts for 40%～70% of polyisobutylene gross weight; Preferably the polyisobutylene of small-molecular weight accounts for 40%～50% of polyisobutylene gross weight, and the polyisobutylene of macromolecule accounts for 50%～60% of polyisobutylene gross weight.Can be to adopt the polyisobutylene of two or more model to form during concrete the making.
The effect of solvent is for the polyisobutylene swelling, be beneficial to beat the glue coating, solvent commonly used is Carbon bisulfide, normal hexane, cyclohexane extraction, heptane, chloroform, acetone, petroleum ether, ether, various aliphatic hydrocarbons or aromatic hydrocarbon, wherein the most general with the use of the gasoline in the aliphatic hydrocarbon again, and effect is better.The consumption of solvent is the whole swellings of polyisobutylene to be softened be advisable, and generally is 1～4 times of polyisobutylene weight.Solvent can be to go up a kind of in the number compositions, also can be in the above-mentioned composition any two or more, with the blended mixture of arbitrary proportion.
Swelling is softening better in order to make polyisobutylene, also for the ease of the dispersion processing of many compositions, improve the fast viscous force of plaster simultaneously, generally can in substrate, add softening agent, softening agent commonly used is liquid paraffin, lanoline, Yellow Vaselin, white vaseline etc., softening agent can be a kind of, also can be two or more mixture that forms with the arbitrary proportion combination in any.
In order to increase the absorbent properties of plaster, can also in substrate, add Percutaneous absorption enhancer, Percutaneous absorption enhancer commonly used is AZONE and analog thereof, alcohols and polyalcohols, pyrrolones etc., as AZONE, ethanol, isopropyl alcohol, glycerol, 2-pyrrolidone etc., Percutaneous absorption enhancer can be a kind of, also can be that two or more is with any blended mixture of arbitrary proportion.
Interfacial adhesion intensity and plasticising performance in order to improve plaster also can add viscosifier in the substrate.Viscosifier can be natural or synthetic resin, as cyclopentadiene, isoprene, Foral, Foral glyceride, terpene resin and Petropols etc.Viscosifier can be a kind of, also can be two or more mixture that forms with any mixing of any proportional quantity.
Also can add age resistor in this Chinese medicine plaster stroma, but polyisobutylene is a synthesized polymer material, its performance is more stable, and age resistor commonly used is strong sensitinogen, so can not add age resistor generally speaking.
The proportional quantity of this Chinese medicine plaster stroma each component (in weight portion :)
Polyisobutylene 10～90, viscosifier 0～80, softening agent 0～40, filler 0～40, Percutaneous absorption enhancer 0～10, solvent 10～360
Wherein polyisobutylene is the mixture of the polyisobutylene of small-molecular weight and macromolecule, and the proportioning (weight) between small-molecular weight and the macromolecule polyisobutylene is micromolecule polyisobutylene 10～60%, macromole polyisobutylene 40～90%.
Optimal components ratio (weight) is a micromolecule polyisobutylene 30～60%, macromole polyisobutylene 40～70%, and best proportioning (weight) is a micromolecule polyisobutylene 40～50%, macromole polyisobutylene 50～60%.
The optimum ratio amount of above-mentioned Chinese medicine plaster stroma each component (in weight portion :)
Polyisobutylene 30～80, viscosifier 20～80, softening agent 20～40, filler 20～40, Percutaneous absorption enhancer 0～5, solvent 30～320.
The best proportional quantity of above-mentioned each component of Chinese medicine plaster stroma (in weight portion :)
Polyisobutylene 40～60, viscosifier 30～50, softening agent 25～35, filler 30～40, Percutaneous absorption enhancer 0～3, solvent 40～240.
The preparation method of above-mentioned substrate is to take by weighing each substrate component soaked in solvent by proportional quantity, and is softening to whole swellings, stir, mix Chinese medicine plaster stroma of the present invention.If add Chinese medical concrete again in substrate, slurrying, coating, drying, section, packing get Chinese medicine plaster of the present invention.Wherein the ratio of Chinese medical concrete adding generally is to add 1～40 parts by weight of Chinese traditional medicine extractum in above-mentioned matrix formulations, and its better ratio is 10～30 weight portions, preferably 15～25 weight portions; The proportional quantity that is to say Chinese medicine plaster each component following (in weight portion :)
Polyisobutylene 10～90, viscosifier 0～80, softening agent 0～40, filler 0～40, Percutaneous absorption enhancer 0～10, solvent 10～360, Chinese medical concrete 1～40.
Wherein polyisobutylene is the mixture of the polyisobutylene of small-molecular weight and macromolecule, and the proportioning (weight) between small-molecular weight and the macromolecule polyisobutylene is micromolecule polyisobutylene 10～60%, macromole polyisobutylene 40～90%.
Optimal components ratio (weight) is a micromolecule polyisobutylene 30～60%, macromole polyisobutylene 40～70%, and best proportioning (weight) is a micromolecule polyisobutylene 40～50%, macromole polyisobutylene 50～60%.
The optimum ratio amount of above-mentioned Chinese medicine plaster each component is (in weight portion :)
Polyisobutylene 30～80, viscosifier 20～80, softening agent 20～40, filler 20～40, Percutaneous absorption enhancer 0～5, solvent 30～320, Chinese medical concrete 10～30.
The best proportional quantity of above-mentioned each component of Chinese medicine plaster is (in weight portion :)
Polyisobutylene 40～60, viscosifier 30～50, softening agent 25～35, filler 30～40, Percutaneous absorption enhancer 0～3, solvent 40～240, Chinese medical concrete 15～25.
Plaster stroma of the present invention has following advantage:
(1) substrate composition uniqueness, safety non-toxic, can not produce stimulation to skin: the Chinese medicine plaster adopted rubber as the substrate Main Ingredients and Appearance mostly in the past, because rubber contains the toxalbumin to sensitization of skin, skin pastes with just producing skin whiting, scratchy and generation erythema after a few hours usually.Adopt the Main Ingredients and Appearance of polyisobutylene as substrate, it is the main carrier glue of chewing gum, has been proved to be the medicinal auxilliary system of safety non-toxic.Therefore fundamentally overcome zest, the sensitization problem of substrate, reduced the skin allergy rate skin.
(2) prescription is unique: the novel high polymer material polyisobutylene is carried out special formulation, and orthogonal test the is preferred prescription of suitable Chinese medicine plaster adopts international advanced Percutaneous absorption enhancer to improve the product curative effect.
(3) preparation technology: developed the big production technology of substrate, energy large-scale production, yield rate height.Reduce the glue time than rubber unguentum, simplified technology, avoid the destruction of volatile medicine.
(4) the pharmaceutical pack capacity is bigger: polyisobutylene Western medicine patch content of dispersion is milligram level level, and by matrix formulations research, the art of this patent has solved the containing of polyisobutenyl confrontation Chinese medicine and measured this key technology difficult point, and Chinese medicine content is reached more than 20%.
(5) viscosity is controlled: it is strong and immutable that the common drawback of general external plaster is that viscosity is crossed.Take to produce epilation peeling phenomenon during use off, Chinese medicine plaster of the present invention can be by regulating the proportion control viscosity of the polyisobutylene sized molecules amount in the substrate, make its sticking firm, easily peel off,, avoid producing epilation peeling phenomenon.
(6) substrate performance is stable: the polyisobutylene chemical property is stable, is applicable to medicine of different nature, does not change the character and the therapeutical effect of medicine, and weatherability is good, good springiness and hot strength are big, and processing and forming ability uniqueness can be processed into the different various plaster that paste with the position of human body.
The present invention has overcome shortcomings such as the irritated rate height of general traditional plaster, zest is big, epilation peeling phenomenon is serious, viscosity is uncontrollable, widened the Chinese medicine plaster to be suitable for the crowd and to be suitable for sick the kind, and be to traditional plaster breakthrough innovation.Different with existing polyisobutylene plaster stroma, polyisobutylene plaster stroma of the present invention need not branch bin-storing layer and adhered layer, but bin-storing layer and adhered layer unite two into one, be that drug transdermal is rapider, more direct, utilization ratio of drug is higher, the local blood drug level in affected part is bigger, the more remarkable treatment effect of plaster.
(4) specific embodiment:
Be several non-limiting examples of the present invention below.
Embodiment one:
30 parts of polyisobutylene B-100
20 parts of polyisobutylene B-3
15 parts of hydrogenated rosin glycerides
20 parts of liquid paraffin
14 parts of zinc oxide
1 part of AZONE
120 parts in gasoline
30 parts of Chinese medical concretes (damp-affection and pain relieving extractum)
Preparation method: take by weighing each substrate component soaked in solvent by proportional quantity, softening to whole swellings, stir, mix Chinese medicine plaster stroma of the present invention, in substrate, add Chinese medical concrete again, slurrying, coating, drying, section, packing, Chinese medicine plaster of the present invention.
Embodiment two:
30 parts of polyisobutylene B-150
10 parts of polyisobutylene B-100
20 parts of polyisobutylene B-1
15 parts of liquid paraffin
15 parts in vaseline
18 parts of magnesium oxide
2 parts of AZONE
150 parts of normal hexane
25 parts of Chinese medical concretes (chasing after wind extractum)
Preparation method is the same.
Embodiment three:
30 parts of polyisobutylene B-100
10 parts of polyisobutylene B-10
20 parts of polyisobutylene B-3
10 parts of terpene resins
15 parts of lanolines
2 parts of AZONE
150 parts of cyclohexane extraction
20 parts of preparation methoies of Chinese medical concrete (bone leads to extractum) are the same.
Embodiment four:
60 parts of polyisobutylene B-100
20 parts of polyisobutylene B-3
20 parts of polyisobutylene B-1
150 parts in gasoline
5 parts of ethanol
15 parts of Chinese medical concretes (bone leads to extractum)
Preparation method is the same.
Claims (18)
1, a kind of Chinese medicine plaster stroma is characterized in that it is made of following component:
Polyisobutylene 10～90 viscosifier 0～80 softening agent 0～40 filler 0～40 Percutaneous absorption enhancer 0～10 solvent 10～360
Above-mentioned component is all in weight portion, and wherein polyisobutylene is the mixture of the polyisobutylene of small-molecular weight and macromolecule.
2, a kind of Chinese medicine plaster stroma according to claim 1, the each component proportional quantity is:
Polyisobutylene 30～80 viscosifier 20～60 softening agents 20～40 filleies 20～40
Percutaneous absorption enhancer 0～5 solvent 30～320
Above-mentioned component is all in weight portion.
3, a kind of Chinese medicine plaster stroma according to claim 2, the each component proportional quantity is:
Polyisobutylene 40～60 viscosifier 30～50 softening agents 25～35 filleies 30～40
Percutaneous absorption enhancer 0～3 solvent 40～240
Above-mentioned component is all in weight portion.
4, according to any one described a kind of Chinese medicine plaster stroma in the claim 1～3, it is characterized in that: the polyisobutylene of wherein said small-molecular weight accounts for 10%～60% of polyisobutylene gross weight, and the polyisobutylene of macromolecule accounts for 40%～90% of polyisobutylene gross weight.
5, a kind of Chinese medicine plaster stroma according to claim 4, it is characterized in that: the polyisobutylene of small-molecular weight accounts for 30%～60% of polyisobutylene gross weight, and the polyisobutylene of macromolecule accounts for 40%～70% of polyisobutylene gross weight.
6, a kind of Chinese medicine plaster stroma according to claim 4, it is characterized in that: the polyisobutylene of small-molecular weight accounts for 40%～50% of polyisobutylene gross weight, and the polyisobutylene of macromolecule accounts for 50%～60% of polyisobutylene gross weight.
7, according to any one described a kind of Chinese medicine plaster stroma in the claim 1～3, it is characterized in that: described viscosifier are natural or synthetic resin.
8, a kind of Chinese medicine plaster stroma according to claim 7, it is characterized in that: described natural or resin is cyclopentadiene, isoprene, Foral, Foral glyceride, terpene resin or Petropols, or the arbitrary composition of proportional quantity arbitrarily between above-mentioned substance.
9, according to any one described a kind of Chinese medicine plaster stroma in the claim 1～3, it is characterized in that: described softening agent is the arbitrary composition of any proportional quantity between liquid paraffin, lanoline, Yellow Vaselin, white vaseline or above-mentioned substance.
10, according to any one described a kind of Chinese medicine plaster stroma in the claim 1～3, it is characterized in that: described filler is the arbitrary composition of zinc oxide, titanium dioxide, silica gel, aluminium hydroxide, aluminium oxide, Pulvis Talci, Gypsum Fibrosum powder, lithopone, magnesium oxide or any proportional quantity of above-mentioned substance.
11, according to any one described a kind of Chinese medicine plaster stroma in the claim 1～3, it is characterized in that: described Percutaneous absorption enhancer is the arbitrary composition of AZONE and analog, alcohols and polyalcohols, pyrrolones or any proportional quantity of above-mentioned substance.
12, according to any one described a kind of Chinese medicine plaster stroma in the claim 1～3, it is characterized in that: described solvent is Carbon bisulfide, normal hexane, cyclohexane extraction, heptane, chloroform, acetone, petroleum ether, ether, various aliphatic hydrocarbons or aromatic hydrocarbon, or the arbitrary composition of any proportional quantity of above-mentioned substance.
13, a kind of Chinese medicine plaster stroma according to claim 12, it is characterized in that: described solvent is a gasoline.
14, according to the preparation method of the described a kind of Chinese medicine plaster stroma of claim 1～13, it is characterized in that: take by weighing each substrate component soaked in solvent by proportional quantity, softening to whole swellings, stir, mix Chinese medicine plaster stroma of the present invention.
15, the Chinese medicine plaster made from substrate described in the claim 1～13 is characterized in that: be added with 1～40 parts by weight of Chinese traditional medicine extractum in substrate.
16, according to the described Chinese medicine plaster of claim 15, it is characterized in that: in substrate, be added with 10～30 parts by weight of Chinese traditional medicine extractum.
17, according to the described Chinese medicine plaster of claim 16, it is characterized in that: in substrate, be added with 15～25 parts by weight of Chinese traditional medicine extractum.
18, the preparation method of the described Chinese medicine plaster of claim 15～17, it is characterized in that: take by weighing each substrate component soaked in solvent by proportional quantity, to all softening, stirrings of swelling, mix Chinese medicine plaster stroma of the present invention, in substrate, add Chinese medical concrete again, slurrying, coating, drying, section, packing get Chinese medicine plaster of the present invention.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 03135244 CN1251668C (en) | 2003-06-13 | 2003-06-13 | Ground substance and plaster of Chinese traditional medicine as well as its preparing method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 03135244 CN1251668C (en) | 2003-06-13 | 2003-06-13 | Ground substance and plaster of Chinese traditional medicine as well as its preparing method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1480129A true CN1480129A (en) | 2004-03-10 |
| CN1251668C CN1251668C (en) | 2006-04-19 |
Family
ID=34154543
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 03135244 Expired - Lifetime CN1251668C (en) | 2003-06-13 | 2003-06-13 | Ground substance and plaster of Chinese traditional medicine as well as its preparing method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1251668C (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104840449A (en) * | 2015-04-22 | 2015-08-19 | 崔建平 | Medical patch and preparation method thereof |
| CN105343035A (en) * | 2015-11-30 | 2016-02-24 | 江苏七O七天然制药有限公司 | Preparation process of plaster |
| CN109908112A (en) * | 2019-04-19 | 2019-06-21 | 内蒙古科尔沁药业有限公司 | A kind of rubber paste emplastrum of not allergy and preparation method thereof |
| CN110613701A (en) * | 2019-07-09 | 2019-12-27 | 张娟玲 | Rosin plaster matrix, rosin plaster using the same and preparation method thereof |
| CN110755411A (en) * | 2019-12-06 | 2020-02-07 | 湖南富兴飞鸽药业有限公司 | Traditional Chinese medicine plaster substrate, traditional Chinese medicine plaster and preparation method thereof |
| CN110934737A (en) * | 2019-12-06 | 2020-03-31 | 湖南富兴飞鸽药业有限公司 | Traditional Chinese medicine plaster for moxibustion and preparation method thereof |
| CN112007166A (en) * | 2019-05-31 | 2020-12-01 | 邓启焕 | Polyisobutylene traditional Chinese medicine plaster matrix and preparation method thereof |
-
2003
- 2003-06-13 CN CN 03135244 patent/CN1251668C/en not_active Expired - Lifetime
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104840449A (en) * | 2015-04-22 | 2015-08-19 | 崔建平 | Medical patch and preparation method thereof |
| CN104840449B (en) * | 2015-04-22 | 2018-05-18 | 崔建平 | A kind of medicine patch and preparation method thereof |
| CN105343035A (en) * | 2015-11-30 | 2016-02-24 | 江苏七O七天然制药有限公司 | Preparation process of plaster |
| CN109908112A (en) * | 2019-04-19 | 2019-06-21 | 内蒙古科尔沁药业有限公司 | A kind of rubber paste emplastrum of not allergy and preparation method thereof |
| CN109908112B (en) * | 2019-04-19 | 2022-04-19 | 内蒙古科尔沁药业有限公司 | Non-allergic rubber plaster and preparation method thereof |
| CN112007166A (en) * | 2019-05-31 | 2020-12-01 | 邓启焕 | Polyisobutylene traditional Chinese medicine plaster matrix and preparation method thereof |
| CN110613701A (en) * | 2019-07-09 | 2019-12-27 | 张娟玲 | Rosin plaster matrix, rosin plaster using the same and preparation method thereof |
| CN110755411A (en) * | 2019-12-06 | 2020-02-07 | 湖南富兴飞鸽药业有限公司 | Traditional Chinese medicine plaster substrate, traditional Chinese medicine plaster and preparation method thereof |
| CN110934737A (en) * | 2019-12-06 | 2020-03-31 | 湖南富兴飞鸽药业有限公司 | Traditional Chinese medicine plaster for moxibustion and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1251668C (en) | 2006-04-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI317273B (en) | Adhesive preparation and use thereof | |
| CN1800289A (en) | Hot-melt pressure-sensitive adhesive type matrix for medical use and its preparation | |
| CN111214429B (en) | Repair essence and preparation method thereof | |
| CN1194671C (en) | Sheet-form adhesive preparation | |
| CN1416885A (en) | Andrographis gel as supplementary medicine for treating preiodontitis | |
| CN1251668C (en) | Ground substance and plaster of Chinese traditional medicine as well as its preparing method | |
| KR100946605B1 (en) | Anti-inflammatory analgesic adhesive patch | |
| TW206152B (en) | ||
| CN101361975A (en) | Medical plaster hot-melt adhesive ground substance, traditional Chinese medicine plaster using the ground substance and preparation method thereof | |
| CN106822049B (en) | Novel chemical medicine patch ketoprofen patch and preparation method thereof | |
| EP2776045A1 (en) | A hydrocolloid composition and an article containing the same | |
| CN106692110B (en) | aryl propionic acid non-steroidal anti-inflammatory drug patch and preparation method thereof | |
| CN101288772B (en) | Novel medical hot melt resin carrier gel matrix and its preparation method and application | |
| CN101020019A (en) | Dogskin plaster and its prepn process | |
| CN110090198A (en) | A kind of slow-release canker sore gel and preparation method thereof with bioadhesive | |
| CN1070051C (en) | Substrate for medical paste | |
| CN1414856A (en) | Antiprurity agents for external use | |
| CN1552308A (en) | Nano spectrum endermatic medicinal paste and its preparation | |
| CN112891325A (en) | Preparation and application of ketorolac patch | |
| CN1269206A (en) | Making process of Babu plaster for rheumatism and ostealiga | |
| CN109675088A (en) | A kind of ageing-resistant antibacterial medical pressure-sensitive adhesive agent and preparation method thereof | |
| JP4958477B2 (en) | A poultice for reducing hay fever | |
| CN109700876A (en) | A kind of oxidation resistant particle is sufficient to paste pack and preparation method thereof | |
| CN113509509B (en) | Traditional Chinese medicine emplastrum for reducing hyperglycemia and preparation method thereof | |
| CN1215831C (en) | Chinese medicine cataplasm matrix and preparing technique thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C56 | Change in the name or address of the patentee |
Owner name: GUILIN HUARUN TIANHE PHARMACEUTICAL CO., LTD. Free format text: FORMER NAME: TIANHE PHARMACY INDUSTRY CO., LTD., GULIN |
|
| CP01 | Change in the name or title of a patent holder |
Address after: 541001 No. 1, Fu He road, Guilin, the Guangxi Zhuang Autonomous Region Patentee after: GUILIN HUARUN TIANHE PHARMACEUTICAL Co.,Ltd. Address before: 541001 No. 1, Fu He road, Guilin, the Guangxi Zhuang Autonomous Region Patentee before: Guilin Tianhe Pharmaceutical Co.,Ltd. |
|
| CX01 | Expiry of patent term |
Granted publication date: 20060419 |
|
| CX01 | Expiry of patent term |